Subscribe to RSS
DOI: 10.1055/s-2001-14549
Endovascular Local Thrombolytic Therapy of Ileofemoral and Inferior Caval Vein Thrombosis
Publication History
Publication Date:
31 December 2001 (online)
ABSTRACT
The intrathrombus delivery of thrombolytic agent to patients with deep vein thrombosis extending above the groin was introduced in the early 1990s as an alternative to systemic thrombolysis. The technique requires proper positioning of an indwelling catheter with its tip into the thrombus. Up to now urokinase as well as alteplase have been used in different dosage schemes. Repeated injection of contrast fluid monitors progress of treatment. Rapid lysis with restoration of patency is achieved in roughly three of four patients treated, usually with prompt clinical improvement. Underlying stenotic lesions are frequently relieved by insertion of metallic stents. Data on long term patency are still scarce, and no comparative trials with conventional anticoagulation are available. Bleeding is the most feared complication, and a few serious bleeding incidents have been reported. Local thrombolysis appears an interesting but labor-intensive approach in expert hands, but a definite place in management of venous thrombosis remains to be established.
KEYWORD
Endovascular local thrombolytic therapy - deep vein thrombosis - thrombolytic therapy - venous thrombosis management
REFERENCES
- 1 Plate G, Einarsson E, Ohlin P. Thrombectomy with temporary arteriovenous fistula: the treatment of choice in acute iliofemoral venous thrombosis. J Vasc Surg . 1984; 1 867-876
- 2 Plate G, Akeson H, Einarsson E. Long-term results of venous thrombectomy combined with a temporary arteriovenous fistula. Eur J Vasc Surg . 1990; 4 483-489
- 3 Goldhaber S Z, Buring J E, Lipnick R J, Hennekens C H. Pooled analysis of randomized trials of streptokinase and heparin in phlebographically documented acute deep venous thrombosis. Am J Med . 1984; 76 393-397
- 4 Bounameaux H, Banga J A, Bluhmki E. Double-blind, randomized comparison of systemic continuous infusion of 0.25 versus 0.50 mg/kg/24h of alteplase over 3 to 7 days for treatment of deep venous thrombosis in heparinized patients: results of the European thrombolysis with rt-PA in venous thrombosis (ETTT) trial. Thromb Haemost . 1992; 67 306-309
- 5 Working Party on Thrombolysis in the Management of Limb Ischemia. Thrombolysis in the management of limb peripheral arterial occlusion-a consensus document. Am J Cardiol . 1998; 81 207-218
- 6 Mewissen M W, Seabrook G R, Meissner M H. Catheter-directed thrombolysis for lower extremity deep venous thrombosis: report of a National Multicenter Registry. Radiology . 1999; 211 39-49
- 7 Semba C P, Dake M D. Iliofemoral deep venous thrombosis: aggressive therapy with catheter-directed thrombolysis. Radiology . 1994; 191 487-494
- 8 Verhaeghe R, Stockx L, Lacroix H, Vermylen J, Baert A L. Catheter-directed lysis of iliofemoral vein thrombosis with use of rt-PA. Eur Radiol . 1997; 7 996-1001
- 9 Angle J F, Matsumoto A H, Al Shammari M. Transcatheter regional urokinase therapy in the management of inferior vena cava thrombosis. JVIR . 1998; 9 917-925
- 10 Bjarnason H, Kruse J R, Asinger D A. Iliofemoral deep venous thrombosis: safety and efficacy outcome during 5 years of catheter-directed thrombolytic therapy. JVIR . 1997; 8 405-418
- 11 Heymans S, Verhaeghe R, Stockx L, Collen D. Feasibility study of catheter-directed thrombolysis with recombinant staphylokinase in deep vein thrombosis. Thromb Haemost . 1998; 79 517-519
- 12 Comerota A J, Throm R C, Mathias S D, Haughton S, Mewissen M. Catheter-directed thrombolysis for iliofemral deep venous thrombosis improves health-related quality of life. J Vasc Surg . 2000; 32 130-137
- 13 Comerota A J, Aldridge S C, Cohen G. A strategy of aggressive regional therapy for acute iliofemoral venous thrombosis with contemporary venous thrombectomy or catheter-directed thrombolysis. J Vasc Surg . 1994; 20 244-254